8-89784141-TAAA-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_003821.6(RIPK2):c.1029+23_1029+25del variant causes a splice donor 5th base, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.254 in 546,772 control chromosomes in the GnomAD database, including 7,113 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.37 ( 5666 hom., cov: 0)
Exomes 𝑓: 0.23 ( 1447 hom. )
Consequence
RIPK2
NM_003821.6 splice_donor_5th_base, intron
NM_003821.6 splice_donor_5th_base, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.769
Genes affected
RIPK2 (HGNC:10020): (receptor interacting serine/threonine kinase 2) This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 8-89784141-TAAA-T is Benign according to our data. Variant chr8-89784141-TAAA-T is described in ClinVar as [Benign]. Clinvar id is 403380.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.435 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RIPK2 | NM_003821.6 | c.1029+23_1029+25del | splice_donor_5th_base_variant, intron_variant | ENST00000220751.5 | |||
RIPK2 | NM_001375360.1 | c.618+23_618+25del | splice_donor_5th_base_variant, intron_variant | ||||
RIPK2 | XM_011517357.3 | c.516+23_516+25del | splice_donor_5th_base_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RIPK2 | ENST00000220751.5 | c.1029+23_1029+25del | splice_donor_5th_base_variant, intron_variant | 1 | NM_003821.6 | P1 | |||
RIPK2 | ENST00000522965.1 | c.*668+23_*668+25del | splice_donor_5th_base_variant, intron_variant, NMD_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.368 AC: 35513AN: 96464Hom.: 5668 Cov.: 0
GnomAD3 genomes
AF:
AC:
35513
AN:
96464
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0786 AC: 2247AN: 28604Hom.: 17 AF XY: 0.0737 AC XY: 1120AN XY: 15204
GnomAD3 exomes
AF:
AC:
2247
AN:
28604
Hom.:
AF XY:
AC XY:
1120
AN XY:
15204
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.230 AC: 103588AN: 450302Hom.: 1447 AF XY: 0.226 AC XY: 52857AN XY: 233950
GnomAD4 exome
AF:
AC:
103588
AN:
450302
Hom.:
AF XY:
AC XY:
52857
AN XY:
233950
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.368 AC: 35504AN: 96470Hom.: 5666 Cov.: 0 AF XY: 0.366 AC XY: 16079AN XY: 43924
GnomAD4 genome
AF:
AC:
35504
AN:
96470
Hom.:
Cov.:
0
AF XY:
AC XY:
16079
AN XY:
43924
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at